Pfizer Inc. (PFE): Price and Financial Metrics

PFE POWR Grades

• PFE scores best on the Growth dimension, with a Growth rank ahead of 93.82% of US stocks.
• PFE's strongest trending metric is Value; it's been moving up over the last 48 weeks.
• PFE's current lowest rank is in the Momentum metric (where it is better than 13.9% of US stocks).

PFE Stock Summary

• With a market capitalization of $247,759,558,452, Pfizer Inc has a greater market value than 99.34% of US stocks.
• Pfizer Inc's stock had its IPO on January 1, 1986, making it an older stock than 92.65% of US equities in our set.
• With a year-over-year growth in debt of -38.31%, Pfizer Inc's debt growth rate surpasses just 13.69% of about US stocks.
• If you're looking for stocks that are quantitatively similar to Pfizer Inc, a group of peers worth examining would be LLY, NFLX, CSCO, NVO, and ORCL.
• Visit PFE's SEC page to see the company's official filings. To visit the company's web site, go to www.pfizer.com.

PFE Valuation Summary

• PFE's price/sales ratio is 5; this is 55.95% lower than that of the median Healthcare stock.
• PFE's price/sales ratio has moved down 2.9 over the prior 243 months.
• Over the past 243 months, PFE's price/earnings ratio has gone down 17.6.

Below are key valuation metrics over time for PFE.

PFE Growth Metrics

• Its year over year revenue growth rate is now at -12.24%.
• The 5 year revenue growth rate now stands at 5.71%.
• Its 4 year net income to common stockholders growth rate is now at 107.78%.

Over the past 33 months, PFE's revenue has gone down $1,736,000,000.

The table below shows PFE's growth in key financial areas (numbers in millions of US dollars).

Date	Revenue	Operating Cash Flow	Net Income to Common Stock
2021-06-30	51,637	23,552	13,228
2021-03-31	44,461	15,808	11,091
2020-12-31	41,908	14,403	9,616
2020-09-30	48,648	12,547	8,685
2020-06-30	49,197	14,967	14,171
2020-03-31	50,660	14,023	15,791

PFE's Quality Factors

The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.

• PFE has a Quality Grade of B, ranking ahead of 88.31% of graded US stocks.
• PFE's asset turnover comes in at 0.312 -- ranking 145th of 677 Pharmaceutical Products stocks.
• ASMB, XBIT, and NERV are the stocks whose asset turnover ratios are most correlated with PFE.

The table below shows PFE's key quality metrics over time.